Vaccine Confidence Is Built One Real Answer at a Time

A parent is asking their pediatrician about a vaccine. They haven’t refused it, and they aren’t anti-anything. They have a specific question, about a specific ingredient, or a specific timing concern, or a specific story they read about a specific side effect. What happens in the next two minutes of that conversation will shape whether the child gets the vaccine that day, gets it next month, or does not get it at all.

That two-minute conversation is where vaccine confidence actually gets built or lost. It is also where the industry’s communication has the most influence and, in some places, the least support.

The number that reframes the whole conversation

Vaccines have saved an estimated 154 million lives globally since 1974, according to a 2024 Lancet analysis, with the vast majority of those lives belonging to children under five. That number is the stakes. It is also the reason the conversation matters.

The number that changes how brand teams should think about it, though, is a different one. According to the 2024 Edelman Trust Barometer, 83% of people say they trust doctors to tell them the truth about protecting public health. In an environment where trust in most institutions is collapsing, the physician relationship remains one of the most durable channels of health communication left standing. Vaccine confidence, when it grows, grows through that channel.

Which means the question for a brand team building vaccine communication is not how to convince a hesitant population at scale. The question is how to equip the person that population still trusts to have a two-minute conversation that actually answers what is being asked.

Hesitancy is a category label. The concern underneath it is specific

The word “hesitancy” is a category. The concerns underneath it are specific. A parent worried about aluminum in a vaccine is not asking the same question as a parent worried about the timing of the MMR shot. A patient with a family history of an autoimmune condition is not asking the same question as a patient who once had a bad reaction to an unrelated medication. Someone whose skepticism was formed inside the healthcare system is not asking the same question as someone whose skepticism was formed outside it.

Communication built for hesitancy in the aggregate misses all of these specifics. Communication built for the actual question underneath a specific concern is the only kind that ever moves a real person.

Recent research on healthcare provider training reinforces this. A 2024 study across nursing, pharmacy, and medicine learners found that prior education had left them without the tools to hold vaccine conversations, resulting in what participants described as uncomfortable experiences with patients. A separate 2025 mixed-methods study across European healthcare providers concluded that structured communication training measurably improved HCPs’ confidence in the exam room. The gap is not intent. The gap is the specific communication skill of hearing what a patient is actually asking and answering that.

What the strongest vaccine communication actually does

Vaccine communication that supports HCPs in these conversations does something that most category communication does not. It does not treat the audience as a demographic to be swayed. It treats the audience as a person with a specific question that deserves a specific answer.

Practically, that changes the shape of the work. HCP-facing tools built to support vaccine conversations perform better when they are organized around the actual questions patients ask, not around the topics the brand team wants to cover. Materials that give a physician a two-sentence answer to “should I be worried about aluminum in this vaccine” are more useful than materials that give her a full explanation of adjuvant safety. Answers that acknowledge a parent’s specific concern before addressing it work better than answers that dismiss the concern to get to the reassurance. And communication that names uncertainty honestly, where uncertainty exists, earns more trust than communication that overclaims safety.

None of this is about softening the science. It is about respecting that a person asking a real question deserves a real answer, and that a physician trying to answer well in a short window needs the answer already at hand.

The listening move is the marketing move

The frame that helps most in this category is a simple one. The concern behind a hesitant question is almost always more specific and more reasonable than the label “hesitant” makes it sound. A parent asking about a vaccine is often not refusing the vaccine. They are asking to be heard, and asking to be answered.

Vaccine communication built on that premise doesn’t need to be adversarial, and doesn’t need to fight misinformation with more information. What it needs to do is identify the actual question being asked, prepare a real answer for it, and put that answer in the hands of the physician the patient already trusts.

Confidence built this way compounds. A parent who feels heard about the aluminum question is a parent who comes back next year with the flu-shot question. A patient who feels heard about the timing concern is a patient who becomes an advocate inside their own family. Every real answer landed well is trust that pays interest over time, across many conversations and many seasons.

The category is not one conversation. It is thousands of conversations, happening one at a time, between a person and the doctor they trust. The communication that supports that channel most rigorously is the communication that builds confidence most durably.

If your team is working on how vaccine communication should support the HCPs having these conversations, or how to design materials that meet a patient’s real question with a real answer, that is a conversation we would welcome.